Fri, August 11, 2023

Matthew Biegler Maintained (APTO) at Buy with Decreased Target to $15 on, Aug 11th, 2023

Matthew Biegler of Oppenheimer, Maintained "Aptose Biosciences Inc." (APTO) at Buy with Decreased Target from $50 to $15 on, Aug 11th, 2023.

Matthew has made no other calls on APTO in the last 4 months.



There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $38 on, Monday, June 12th, 2023